论文期刊

取消

高级检索

检索历史清除

首页> Journal of pharmaceutical and biomedical analysis> A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers.

A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers.

导出 OA

翻译打印收藏纠错

作者： Mosaad I,Morsy ^[1] ; Eman G,Nouman ^[1] ; Youmna M,Abdallah ^[1] ; Mourd A,Zainelabdeen ^[1] ; Mohamed M,Darwish ^[1] ; Ahmed Y,Hassan ^[1] ; Amira S,Gouda ^[1] ; Mamdouh R,Rezk ^[2] ; Ahmed M,Abdel-Megied ^[3] ; Hoda M,Marzouk ^[2]

作者单位： Zi Diligence Biocenter, Bioequivalence Research, El-Mokattam, Cairo, Egypt. ^[1] Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, 11562, Cairo, Egypt. ^[2] Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Kafr El-Sheikh University, Kafr El-Sheikh City, Egypt; Mass Spectrometry Center, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 N. Pine Street, Baltimore, MD 21201, USA. Electronic address: ahmed.ali@rx.umaryland.edu. ^[3]

关键词 Bioequivalence study COVID-19 Favipiravir Human plasma LC–MS/MS SARS-CoV-2

主题词酰胺类(Amides);抗病毒药(Antiviral Agents);色谱法, 液相(Chromatography, Liquid);埃及(Egypt);急诊处理(Emergency Treatment);人类(Humans);吡嗪类(Pyrazines);结果可重复性(Reproducibility of Results);串联质谱法(Tandem Mass Spectrometry);治疗等效(Therapeutic Equivalency)

DOI 10.1016/j.jpba.2021.114057

PMID 33831737

发布时间 2022-12-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of pharmaceutical and biomedical analysis

114057页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷